Home›Five systems›Dog Ear Care System
Priority system 1 · Commercial offer with evidence gates

Private-label dog ear care system

Aimo coordinates non-medicated dog ear-cleaner projects, matching ear-wipe projects and coordinated kits for overseas pet brands. The public contracting party is Guangzhou Aimo Pet Products Co., Ltd.; the producing entity, site, production scope and project test pack must be confirmed in the written quotation and evidence file before an order.

Submit a project briefSee decision specification
Verified role statedEvidence gateNon-medicated laneMOQ boundariesLast verified 2 September 2026
Direct procurement answer

What can a buyer rely on today?

Guangzhou Aimo Pet Products Co., Ltd. is the public brand, commercial and export counterparty. Commercial terms for standard configurations are owner-confirmed. Manufacturing-site and dual-line evidence remain a buyer-verification gate.

This wording deliberately separates a commercial offer from a factory certificate, completed audit, test result or regulatory approval.

Concept presentation for Dog Ear Care System private-label project

Project architecture

Offer: non-medicated ear-cleaning liquid + ear finger wipes + coordinated kit.

Best-fit buyers: pet brands, private-label retailers, distributors and groomer-channel buyers.

MOQ rule: Liquid: from approximately 3,000 units per SKU using a stock bottle. Ear wipes: from approximately 10,000 packs per SKU. Decoration, custom components and pack format can increase the binding minimum.

Sample rule: Normally 7–10 calendar days after a complete brief and receipt of any reference sample; revisions, unavailable raw materials and courier time are excluded. Qualified B2B samples are free; buyer covers courier.

Specify the format before asking for a quote

FormatProcurement definition
Liquid cleanerWater-based, non-medicated grooming direction; alcohol-free or low-alcohol direction subject to formula review.
Ear finger wipesWipe size, basis weight, texture, lotion loading, count and pack are specified in the approved brief.
Coordinated kitBottle and wipe can share artwork direction and launch timing; do not infer one factory or one site until evidence is supplied.
Use-case variantsAfter-swim or drop-ear positioning may be explored as grooming use cases without infection, treatment or prevention claims.
Claims boundary
  • No treatment, prevention, antibacterial, antifungal, anti-mite or infection claims.
  • No claim that a proposed ingredient system is a finished tested formula.
  • No blanket statement that all markets classify or accept the product identically.

Evidence pack required before production approval

01 · Producing legal entity and site

Confirm subject, issuer/owner, method or scope, date, limitations and whether the item is safe to disclose.

02 · Liquid-filling and wipe-converting scope

Confirm subject, issuer/owner, method or scope, date, limitations and whether the item is safe to disclose.

03 · Formula/specification approval

Confirm subject, issuer/owner, method or scope, date, limitations and whether the item is safe to disclose.

04 · Microbiology, challenge and stability plan for the exact SKU

Confirm subject, issuer/owner, method or scope, date, limitations and whether the item is safe to disclose.

05 · Released batch COA and traceability documents

Confirm subject, issuer/owner, method or scope, date, limitations and whether the item is safe to disclose.

A buyer can review the cross-category status matrix in Aimo’s five-product OEM readiness room. A company statement is not the same as an independent certificate or test report.

Buyer questions, answered without overclaiming

What exactly is Aimo offering?
A private-label project for a non-medicated dog ear-cleaning liquid, an ear finger wipe, or a coordinated set. The exact producer, formula, pack and test package are confirmed project by project.
Is Aimo itself the manufacturing legal entity?
The confirmed public role of Guangzhou Aimo Pet Products Co., Ltd. is the pet-care brand, commercial and export counterparty. Buyers should request the producing entity name, site and relationship before approval.
Is the product medicated?
The promoted lane is routine, non-medicated grooming only. Aimo does not promise treatment, infection prevention, antibacterial, antifungal or mite-control claims.
Can liquid and wipes be coordinated?
Yes as a sourcing project. Whether they are produced by one related group, one site or separate approved producers must be demonstrated by the project evidence pack rather than assumed from marketing copy.
What is the MOQ?
Approximately 3,000 units per liquid SKU on a stock bottle and approximately 10,000 packs per wipe SKU, subject to formula, pack, printing and component review.
What evidence should a buyer request?
Producing-entity licence, site scope, applicable GMP document, approved specification, test plan and reports for the exact SKU, batch COA, traceability and retained-sample procedure.
Project intake

Send the variables that control feasibility and MOQ

Include target market, product form, annual volume, reference SKU, formula/claim direction, pack size, closure, decoration and desired launch date. Aimo will return a question list and evidence plan before presenting an unsupported factory promise.

alex@aimopet.com
+86-150-1420-2977